Eyecelerator @ ARVO 2026
Save the Date: Eyecelerator @ AAO 2026 | Oct. 8 | New Orleans
CONFERENCE SPEAKERS
Switchboard
Blake Anderson, MD
CEO & CTO
CU Innovations
Gali Baler, PhD
Managing Director, Strategy and Operations
Alcon
Roshni Bhagalia, PhD
VP-Digital Products, Surgical
AbbVie
Austin Blackwell
Head of Marketing, Retina
CDHR
Bradley Cunningham (remote)
MSE
EyePoint
Jay S. Duker, MD
President & CEO
Topcon Healthcare
Daniela Ferrara, MD, PhD
Chief Medical Officer
Ray Technologies
Peter Francis, MD, PhD
Chief Scientific and Medical Officer
Gitkin & Co.
Andrew Gitkin
Managing Partner
New England Eye Center
Michael Goldstein, MD
Co-Director, Cornea Service
Visionary Ventures
Garrett Hamontree, MBA
Partner
Science Corporation
​
Ralf Hornig, PhD
Director, Clinical Affairs
Verana Health
Sujay Jadhav, MBA
CEO
InterWest Partners​
Gil Kliman, MD
Managing Partner, Program Director
American Academy of Ophthalmology
Stephen D. McLeod, MD
CEO​, Program Committee
Glaukos​​
Tomas Navratil, PhD
Chief Development Officer
Re-Vana Therapeutics
Michael J. O’Rourke
CEO
Ufonia
Nick de Pennington, FRCS
CEO
Horizon Surgical Systems
Rajesh K. Rajpal, MD
Chief Strategy and Medical Officer
Doheny Eye Institute
Srinivas Sadda, MD
Professor and Program Committee
University of California
Julie M. Schallhorn, MD, MS
​Professor and Program Co-Chair
Stanford Medicine​
Kuldev Singh, MD, MPH
Professor of Ophthalmology and Program Co-Chair
AbbVie
Julian Smith
​General Manager, Eye Care Pipeline Commercial Strategy
Duke University
Lejla Vajzovic, MD
Associate Professor of Ophthalmology
Genentech
Henry Wiley, MD
Lead Medical Director
California Retina Consultants
Robert L. Avery, MD
Founder/CEO, Program Co-Chair
CDER, FDA
Heidi I. Becker, MD
Ophthalmology Clinical Reviewer
National Eye Institute, NIH
Kapil Bharti, PhD
Scientific Director
Genentech
Christopher Brittain
Global Head of Ophthalmology Product Development
Ocular Therapeutix
Pravin U. Dugel, MD
President & CEO
Emory Eye Center
Ross Ethier, PhD
Professor of Ophthalmology and Program Committee
Revelation Partners
Doug Fisher, MD
Partner
Eli Lilly and Company
Carl Garner, PhD
SVP, Global Regulatory Affairs and Head
AbbVie
Kelly Giuffrida
Vice President, Eye Care
Foundation Fighting Blindness RD fund
Adrienne Graves, PhD
Board Chair
Wills Eye Hospital
Allen C. Ho, MD
Director of Retina Research, Retina Program Director
UCS Ginsburg Institute for Biomedical Therapeutics
Mark Humayun, MD, PhD
Director
Astellas
Erin Kimbrel, PhD
Head of Cell & Gene Therapy Research​
Ocugen
Uday Kompella, PhD
Founder
Nanoscope Therapeutics
Samarendra Mohanty
President & Co-Founder
Strategic Intelligence, Inc.
Babak Nemati, PhD
Founder and CEO
UCSF Innovation Ventures
Mike Papac, PhD
Head, Ophthalmic Business Development
ExSight Ventures, LLC
Firas M. Rahhal, MD
Partner
ARVO
Iris Rush, CAE
Executive Director
Ocular Therapeutix, Inc.
Namrata Saroj, OD
Chief Business Officer
Boston Consulting Group
Long Sha, PhD
Partner
Nuerotech
Rich Small
CEO
CBER
Katerina Tsilou, MD (remote)
Team Leader
​
Visionary Ventures
Jeffry Weinhuff
Managing Partner
MedTech Venture Partners
Christine Winoto
Founding Partner